KRTL Biotech
With approval by the Korean FDA, working with a consortium of experienced Korean and US doctors and researchers on developing and conducting trials on unique fungi and psychedelic targeting various mental health conditions
KRTL Biotech Inc is a U.S. research and development company now working in Korea through KRTL Asia, with a consortium of experienced Korean and US doctors and researchers dedicated to improving mankind’s debilitating physical and mental ailments with progressive pre-formulations created by its organization.
​
KRTL is a biotech company instituting a facet of studies, with pharmaceutical grade resources and technologies as well as disciplines in the CBD, Psilocybin and certain psychedelics arena. The company’s scientists are leaders in cancer and neurology research, with over 80 years of experience in the research industry. KRTL Biotech Inc. has obtained the coveted approval of Korea’s Ministry of Food and Drug Safety (MFDS), formerly known as the Korea Food & Drug Administration (KFDA). The company has partnered with a multitude of universities and biotech companies to facilitate this venture.
​
Our investment in KRTL Biotech provides us with a front seat to the world of medical fungi research and entry to a global network of institutions, scientists, and early market entrants, shaping our strategy for investment and acquisitions.